Protalix Biotherapeutics

Developer of recombinant proteins through plant cell-based expression system

placeKarmiel, North District, Israel calendar_todayFounded 1993 groups197 employees language protalix.com

Social engagement

Social engagement: 11.5K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

18 investors on record.

Investor typeCountShare
Venture capital528%
Private equity16%
Bank & private debt16%
Other / undisclosed1161%

Recent activity

1 Jul 2026
Product launch
PRX-115
24 Jun 2026
Event
BIO International Convention 2026
13 May 2026
Milestone
regulatory
Coming soon